Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Agomelatine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102234238B reveals a mild Raney-Ni catalyzed route for Agomelatine intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN103113243A details a mild, high-yield route for Agomelatine intermediates. Discover cost-effective DDQ dehydrogenation and safe reduction strategies.
Patent CN102060733A reveals a high-yield synthesis for agomelatine intermediates using dual catalysis, offering significant cost reduction and scalable manufacturing solutions.
Novel patent CN116924931B details improved Agomelatine synthesis reducing waste and enhancing purity for scalable pharmaceutical intermediate manufacturing supply chains.
Patent CN107162933A reveals catalytic DDQ oxidation for high-purity pharmaceutical intermediates. Achieve cost reduction and scalable supply chain reliability.
Novel catalytic oxidative dehydrogenation route for Agomelatine intermediate. Lower cost, environmentally friendly, and scalable supply chain solutions.
Patent CN102206170A details a mild, one-pot synthesis of Agomelatine using Nickel Chloride, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN101486665B reveals a one-step ammonolysis route for 2-(7-methoxy-1-naphthyl)acetamide, offering significant cost reduction and environmental benefits for API manufacturing.
Patent CN119118862B reveals one-step agomelatine synthesis reducing complexity. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN102942501A details a novel one-pot hydrogenation method for Agomelatine, offering high purity, reduced dimer impurities, and significant cost advantages for pharmaceutical manufacturing.
Patent CN101792400A details a high-yield four-step route for Agomelatine, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN101759591A reveals a greener Agomelatine synthesis using cyclohexane and one-pot acetylation, offering significant cost reduction and high purity for API manufacturers.
Patent CN101643434B details a novel industrial synthesis of Agomelatine using 7-methoxy-1-naphthol, offering significant cost reduction and supply chain reliability for global manufacturers.
Novel industrial route for agomelatine intermediate offering significant cost reduction and supply reliability for global pharmaceutical partners seeking high-purity chemical solutions and scalable manufacturing capabilities today.
Discover a novel synthesis route for 7-methoxy-1-naphthylacetonitrile avoiding expensive DDQ and Pd/C. A cost-effective solution for agomelatine intermediate manufacturing.